Guanfacine Hydrochloride
NDC 24979-198, Guanfacine, tablet, from TWi Pharmaceuticals, Inc..
- Product NDC
- 24979-198
- Status
- Listed
- Labeler
- TWi Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216399
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24979-198 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUANFACINE HYDROCHLORIDE1 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24979-198-01 | 24979019801 | 100 TABLET in 1 BOTTLE (24979-198-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a0c2d95d-805c-4c7d-9733-52073a65218aNADAC price for package 24979019801
GET /v1/drugs/nadac/24979019801
Use it
Look up 24979-198 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24979-198 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24979-198. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.